Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998
Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996
Diag of Occult Muscular Dystrophy:"Chance"Finding of Elevated Serum Aminotransferase Act
J Pediatr 122:254-256, Morse,R.P.&Rosman,N.P., 1993
Long-Term Efficacy and Safety of Deprenyl (Selegiline) in Advanced Parkinson's Disease
Neurol 39:1109-1111, Golbe,L.I.,et al, 1989
Diagnosis & Treatment of Reye's Syndrome
JAMA 246:2441-2444, Dodge,P.R.,et al, 1981
Acute Hepatic Failure Associated with the Use of Sodium Valproate
NEJM 300:962-966, Suchy,F.J.,et al, 1979
Reye's Syndrome in the Adult Patient
Am J Med 67:672-678, Atkins,J.N.,et al, 1979
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Effect of Valproic Acid on Hepatic Function
Neurol 28:961-964, Willmore,L.J.,et al, 1978
Adult Toxoplasmosis Presenting as Polymyositis & Cerebellar Ataxia
Ann Int Med 82:367, Greenlee,J.,et al, 1975